BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 342602)

  • 1. Suppression of natural killer cell cytotoxicity by splenocytes from Corynebacterium parvum-injected, bone marrow-tolerant, and infant mice.
    Savary CA; Lotzová E
    J Immunol; 1978 Jan; 120(1):239-43. PubMed ID: 342602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of murine NK activity induced by Corynebacterium parvum: further characterization and abrogation of suppressor cells.
    Milisauskas VK; Cudkowicz G; Nakamura I
    Cancer Immunol Immunother; 1986; 21(1):51-7. PubMed ID: 2935247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of hyporesponsiveness of natural killer cells to augmentation of activity after multiple treatments with biological response modifiers.
    Saito T; Ruffman R; Welker RD; Herberman RB; Chirigos MA
    Cancer Immunol Immunother; 1985; 19(2):130-5. PubMed ID: 3845849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of combination treatment with alpha-difluoromethylornithine and Corynebacterium parvum on B16 melanoma growth and tumoricidal effector cell generation in vivo.
    Bowlin TL; Rosenberger AL; Sunkara PS
    Cancer Immunol Immunother; 1985; 20(3):214-8. PubMed ID: 3933819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splenocytes from tumor-bearing Corynebacterium parvum treated mice maintain interleukin-2 and -3 activity.
    Roberson AM; Elgert KD
    Cancer Immunol Immunother; 1986; 22(1):49-55. PubMed ID: 2939948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depression of murine natural killer cell cytotoxicity by isobutyl nitrite.
    Lotzová E; Savary CA; Hersh EM; Khan AA; Rosenblum M
    Cancer Immunol Immunother; 1984; 17(2):130-4. PubMed ID: 6235910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and growth of methylcholanthrene-induced tumors in mice with altered immunological status.
    Trutin-Ostović C; Golubić M; Matović M; Marusić M
    Cancer Immunol Immunother; 1986; 23(2):130-6. PubMed ID: 3490910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of in vivo and in vitro effectivity of immune defense against a spontaneously arising, nonlymphoid rat tumor. I. Analysis of natural immune defense.
    Zöller M
    Cancer Immunol Immunother; 1985; 19(3):183-8. PubMed ID: 3847288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of natural killer cells in control of cancer metastasis.
    Hanna N
    Cancer Metastasis Rev; 1982; 1(1):45-64. PubMed ID: 7185419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of natural killer activity and antibody-dependent cellular cytotoxicity in healthy volunteers and in patients with primary lung cancer and metastatic pulmonary tumors.
    Saijo N; Shimizu E; Irimajiri N; Ozaki A; Kimura K; Takizawa T; Niitani H
    J Cancer Res Clin Oncol; 1982; 102(3):195-214. PubMed ID: 7061569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of natural killer cell activity by adherent effusion cells of cancer patients. Suppression of motility, binding capacity and lethal hit of NK cells.
    Uchida A; Colot M; Micksche M
    Br J Cancer; 1984 Jan; 49(1):17-23. PubMed ID: 6691897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on natural killer cell activity and the influence of Corynebacterium parvum on murine T-cell leukemogenesis induced by butylnitrosourea.
    Seidel HJ; Stolz W
    J Cancer Res Clin Oncol; 1984; 107(3):199-205. PubMed ID: 6610680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural cytotoxicity of lymphocytes from lymph nodes draining breast carcinoma and its augmentation by interferon and OK432.
    Yanagawa E; Uchida A; Micksche M
    Cancer Immunol Immunother; 1984; 17(1):1-6. PubMed ID: 6563940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro effects of natural killer cells against Paracoccidioides brasiliensis yeast phase.
    Jimenez BE; Murphy JW
    Infect Immun; 1984 Nov; 46(2):552-8. PubMed ID: 6500701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of mouse natural killer activity by cyclosporin A.
    Yanagihara RH; Adler WH
    Immunology; 1982 Feb; 45(2):325-32. PubMed ID: 6460686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative studies of natural immunity to solid tumours in rats. Persistence of natural immunity throughout reproductive life, and absence of suppressor cells in infant rats.
    Brooks CG; Flannery GR
    Immunology; 1980 Feb; 39(2):187-94. PubMed ID: 6445867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer activity in mice infected with Trypanosoma musculi.
    Albright JW; Huang KY; Albright JF
    Infect Immun; 1983 Jun; 40(3):869-75. PubMed ID: 6406366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular suppression of murine ADCC and NK activities induced by Corynebacterium parvum.
    Milisauskas VK; Cudkowicz G; Nakamura I
    Cancer Immunol Immunother; 1983; 15(2):149-54. PubMed ID: 6347362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased thymic hormone responsive suppressor T lymphocyte function in chronic active hepatitis.
    Mutchnick MG; Schaffner JA; Prieto JA; Weller FE; Goldstein AL
    Dig Dis Sci; 1983 Apr; 28(4):328-34. PubMed ID: 6219866
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.